RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

Photo caption: Only one antiviral medication is approved by the FDA for RSV treatment, and it is administered through a nebulizer. Photo credit: BonNontawat / iStock via Getty Images Plus. Article by Annette Regan and Flor M. Munoz. The Conversation – December 16, 2022.

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and is a common cause of lung infections in young children. […]

Click here to view original web page at theconversation.com